Two Sigma Securities’s Core Laboratories CLB Stock Holding History

Two Sigma Securities’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,600	Closed	-$649K	–	2227
2018 Q3	$649K	Sell	5,600 -3,900	-41%	-$440K	﹤0.01%	1254
2018 Q2	$1.2M	Sell	9,500 -5,400	-36%	-$657K	0.01%	1223
2018 Q1	$1.61M	Buy	+14,900	New	+$1.65M	0.01%	996

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Two Sigma Securities's CLB Position: Q4 2019 in Review

Two Sigma Securities sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 4,820 shares — an estimated $225K sold.

Two Sigma Securities first reported a position in CLB in Q2 2017 and held it in 5 quarters. The position peaked at $913K in Q2 2018. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

Two Sigma Securities reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
Two Sigma Securities sold 4,820 Core Laboratories shares in Q4 2019, an estimated $225K.
Two Sigma Securities first reported a position in Core Laboratories in Q2 2017 and held it in 5 quarters.
Two Sigma Securities's Core Laboratories position peaked at $913K in Q2 2018.
283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Two Sigma Securities's 13F filing for Q4 2019, filed 14 Feb 2020.